SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-23-001168
Filing Date
2023-05-22
Accepted
2023-05-22 17:01:32
Documents
79
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q axim_10q.htm   iXBRL 10-Q 1195595
2 CERTIFICATION axim_ex311.htm EX-31.1 12996
3 CERTIFICATION axim_ex312.htm EX-31.2 13041
4 CERTIFICATION axim_ex321.htm EX-32.1 4696
5 CERTIFICATION axim_ex322.htm EX-32.2 4654
11 axim_10qimg3.jpg GRAPHIC 5134
  Complete submission text file 0001096906-23-001168.txt   6201650

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA axim-20230331.xsd EX-101.SCH 79859
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE axim-20230331_lab.xml EX-101.LAB 403463
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE axim-20230331_cal.xml EX-101.CAL 55738
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axim-20230331_pre.xml EX-101.PRE 350916
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE axim-20230331_def.xml EX-101.DEF 236216
73 EXTRACTED XBRL INSTANCE DOCUMENT axim_10q_htm.xml XML 817760
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54296 | Film No.: 23945404
SIC: 2834 Pharmaceutical Preparations